Details for New Drug Application (NDA): 209351
✉ Email this page to a colleague
The generic ingredient in AMOXICILLIN AND CLAVULANATE POTASSIUM is amoxicillin; clavulanate potassium. There are forty-six drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the amoxicillin; clavulanate potassium profile page.
Summary for 209351
Tradename: | AMOXICILLIN AND CLAVULANATE POTASSIUM |
Applicant: | Deva Holding As |
Ingredient: | amoxicillin; clavulanate potassium |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | FOR SUSPENSION;ORAL | Strength | 600MG/5ML;EQ 42.9MG BASE/5ML | ||||
Approval Date: | Sep 13, 2023 | TE: | AB | RLD: | No |
Complete Access Available with Subscription